GNRSU Stock Crashes 99.99% on Pink Sheets, May 8 2026

GNRSU stock has experienced a catastrophic collapse, plummeting 99.99% to trade at just $0.000001 USD on the OTC Pink Sheets market as of May 8, 2026. The Greenrose Holding Company Inc., a cannabis producer based in Amityville, New York, now carries a market capitalization of only $13 million. This represents one of the most severe declines in penny stock history. The company, which went public in February 2020, has seen its valuation evaporate from a year high of $0.151 to near-worthless levels. Trading volume remains extremely thin at just 145 shares, signaling minimal investor interest. GNRSU stock reflects the broader challenges facing small-cap cannabis companies navigating regulatory uncertainty and market saturation.

What Happened to GNRSU Stock Price

GNRSU stock has suffered an unprecedented collapse that defies typical market movements. The stock fell from its previous close of $0.15 to $0.000001, erasing virtually all shareholder value in a single trading session. This represents a loss of $0.149999 per share, or 99.99933% of the stock’s value.

The 50-day and 200-day moving averages both sit at $0.15, indicating the stock traded at these levels recently before the dramatic crash. The year-to-date decline stands at -99.99977%, while the one-year change shows -99.99995%. With only 145 shares trading and a market cap of $13 million, GNRSU stock has become essentially illiquid. Track GNRSU on Meyka for real-time updates on this distressed security.

Financial Metrics Show Severe Distress

The underlying financial picture reveals why GNRSU stock has collapsed so dramatically. The company’s current ratio stands at just 0.21, meaning it has only 21 cents in current assets for every dollar of current liabilities. This indicates severe liquidity problems and potential insolvency.

Working capital is deeply negative at -$103.4 million, while tangible asset value sits at -$116.3 million. The debt-to-equity ratio of 1.57 shows the company carries substantial leverage relative to shareholder equity. Despite these red flags, the earnings per share is $3.097, though this metric is unreliable given the company’s distressed state. The price-to-earnings ratio of essentially zero reflects the stock’s near-worthless trading price.

Cannabis Industry Headwinds and Regulatory Challenges

Greenrose Holding Company operates in the Drug Manufacturers – Specialty & Generic sector within Healthcare, specifically focusing on medical cannabis cultivation, processing, and packaging. The cannabis industry faces persistent regulatory uncertainty at both federal and state levels, creating significant operational and financial risks.

Small-cap cannabis producers like Greenrose struggle with limited access to capital markets, banking restrictions, and inconsistent state-level regulations. The company employs just 91 full-time workers and operates from its Amityville, New York headquarters. CEO Nicole Conboy leads operations, but the company’s inability to maintain profitability or positive cash flow has eroded investor confidence completely. Many cannabis startups from the 2020 IPO wave have faced similar fates.

Market Sentiment and Trading Activity

GNRSU stock trades on the OTC Pink Sheets, the most speculative tier of over-the-counter markets. This venue attracts distressed companies, penny stocks, and securities with minimal regulatory oversight. The extremely low trading volume of 145 shares demonstrates that virtually no one is buying or selling this stock.

The bid-ask spread on penny stocks like GNRSU is typically enormous, making it nearly impossible for retail investors to exit positions at reasonable prices. Meyka AI’s analysis indicates this security has entered a liquidation phase where shareholder recovery appears unlikely. The company’s enterprise value of $101.4 million vastly exceeds its market cap, suggesting significant debt obligations that equity holders will not recover.

Final Thoughts

GNRSU stock has collapsed 99.99% and represents a complete loss of investor capital. Greenrose Holding Company faces severe financial distress with negative working capital and substantial debt. The cannabis industry’s regulatory challenges and limited capital access have devastated this small-cap producer. With a market cap of $13 million insufficient to cover liabilities, investors should prepare for total loss. This case demonstrates the extreme risks of penny stocks and early-stage cannabis companies.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.